Steven Cohen's NAUT Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 67,938 shares of Nautilus Biotechnology, Inc. (NAUT) worth $127,044, representing 0.00% of the portfolio. First purchased in 2021-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in NAUT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 60,833 shares. Largest reduction occurred in Q3 2021, reducing 64,866 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Nautilus Biotechnology (NAUT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nautilus Biotechnology (NAUT) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -15,105 | Reduce 18.19% | 67,938 | $1.87 |
| Q1 2026 | +22,210 | Add 36.51% | 83,043 | $3.88 |
| Q4 2025 | +60,833 | New Buy | 60,833 | $1.95 |
| Q3 2021 | -64,866 | Sold Out | 0 | $0.00 |
| Q2 2021 | +64,866 | New Buy | 64,866 | $10.10 |
Steven Cohen's Nautilus Biotechnology Investment FAQs
Steven Cohen first purchased Nautilus Biotechnology, Inc. (NAUT) in Q2 2021, acquiring 64,866 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Nautilus Biotechnology, Inc. (NAUT) for 5 quarters since Q2 2021.
Steven Cohen's largest addition to Nautilus Biotechnology, Inc. (NAUT) was in Q2 2021, adding 64,866 shares worth $655,000.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 67,938 shares of Nautilus Biotechnology, Inc. (NAUT), valued at approximately $127,044.
As of the Q2 2026 filing, Nautilus Biotechnology, Inc. (NAUT) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Nautilus Biotechnology, Inc. (NAUT) was 83,043 shares, as reported at the end of Q1 2026.